Few medical specialities have experienced such profound transformation over the past three decades as ophthalmology. Diseases that once carried a prognosis of inevitable blindness can now often be stabilised for many years through advances in diagnostics, pharmacotherapy and surgery. Anti-VEGF therapy has revolutionised the management of neovascular age-related macular degeneration (AMD), reducing rates of legal blindness that were once considered unavoidable.